We serve Chemical Name:2-Fluoro-3-hydroxymethyl-benzoic acid CAS:481075-37-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Fluoro-3-hydroxymethyl-benzoic acid
CAS.NO:481075-37-0
Synonyms:Benzoic acid, 2-fluoro-3-(hydroxymethyl)-;2-Fluoro-3-(hydroxymethyl)benzoic acid;2-Fluoro-3-hydroxymethyl-benzoic acid;PC2643
Molecular Formula:C8H7FO3
Molecular Weight:170.138
HS Code:2918199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:346.6±32.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.575
PSA:57.53000
Exact Mass:170.037918
LogP:0.67
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Benzoic acid, 2-fluoro-3-(hydroxymethyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,PC2643 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Fluoro-3-hydroxymethyl-benzoic acid Use and application,PC2643 technical grade,usp/ep/jp grade.
Related News: After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. Benzyl-(β-brom-propenyl)-aether manufacturers Less than three weeks after unveiling the construction of a new fill-finish facility in Morocco, the Sweden-based company announced it was undergoing construction of another fill-finish plant in India. 3-bromophenyl cyclohexyl sulfone suppliers Wavelength, a more than 30-year-old firm based in Petah Tikva, launched its API CDMO business in early 2020 and currently sports more than 250 customers from 50 countries. 13-Iodulein vendor & factory Patients having Zynteglo treatment for beta thalassaemia also need conditioning treatment to clear out their bone marrow cells before receiving Zynteglo. Healthcare professionals should therefore explicitly inform patients receiving Zynteglo of the increased risk of blood cancers from medicines used in conditioning treatments.,Wavelength, a more than 30-year-old firm based in Petah Tikva, launched its API CDMO business in early 2020 and currently sports more than 250 customers from 50 countries.
